Skip to main content
. 2019 Nov 14;13:3867–3877. doi: 10.2147/DDDT.S212235

Table 4.

Neonatal Outcomes After FET According To The Type Of Endometrial Preparation Treatments

Characteristics Letrozole (n=931) HMG (n=952) Letrozole+HMG (n=1363) P-Valuea P-Valueb P-Valuec P-Vlued P-Valuee P-Valuef
Singleton Births (n=531) Multiple Births (n=400) Singleton Births (n=508) Multiple Births (n=444) Singleton Births (n=885) Multiple Births (n=478)
Stillborn- no (%) 0(0) 2(0) 0(0) 0(0) 1(0.11) 0(0)
Live born- no (%) 531(100) 398(99.5) 508(100) 444(100) 884(0.89) 478(0100)
Gestational weeks at delivery
(weeks)
<32 6(1.12%) 4(2.00%) 6(1.18%) 8(1.80%) 5(0.56%) 10(2.09%) 0.892 0.346 0.491 0.341 0.056 0.925
32–36 33(6.22%) 92(46.00%) 28(5.51%) 232(52.25%) 58(6.55%) 212(44.35%)
≥37 492(92.66%) 104(52.00%) 474(93.31%) 204(45.95%) 822(92.89%) 256(53.56%)
Birth weight (g)
<1500 5(0.94%) 8(2.00%) 5(0.98%) 6(1.35%) 4(0.45%) 8(1.67%) 0.831 0.108 0.291 0.154 0.857 0.086
1500–2499 22(4.14%) 115(28.75%) 25(4.92%) 154(34.68%) 27(3.05%) 171(35.77%)
≥2500 504(94.92%) 277(69.25%) 478(94.10%) 284(63.97%) 853(96.38%) 299(62.56%)
Sex of neonates
Male 258(48.59%) 208(52.00%) 253(49.81%) 231(52.03%) 438(49.49%) 236(49.37%) 0.371 0.478 0.392 0.524 0.231 0.241
Female 273(51.41%) 192(48.00%) 255(50.19%) 213(47.97%) 447(50.51%) 242(50.63%)
Mode of delivery
Vaginal 122(22.98%) 14(3.50%) 134(26.38%) 10(2.26%) 243(27.46%) 14(2.93%) 0.115 0.355 0.069 0.189 0.332 0.386
Cesarean section 409(77.02%) 386(96.50%) 374(73.62%) 434(97.74%) 642(72.54%) 464(97.07%)

Notes: aLetrozole singleton births vs HMG singleton births; bHMG singleton births vs letrozole+HMG singleton births. cLetrozole singleton births vs letrozole+HMG singleton births; dLetrozole multiple births vs HMG multiple births. eHMG multiple births vs letrozole+HMG multiple births. fLetrozole multiple births vs letrozole+HMG multiple births.